Oral Antihyperglycemic Therapy for Type 2 Diabetes

JAMA - Journal of the American Medical Association - United States
doi 10.1001/jama.287.3.373
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Medical Association (AMA)

Related search

Modern Antihyperglycemic Agents Prescribed in Russia for Type 2 Diabetes Mellitus

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Management of Type 2 Diabetes Mellitus: Selecting the Right of Antihyperglycemic Medication

Medical Council
2018English

Which Incretin-Based Therapy for Type 2 Diabetes?

The Lancet
Medicine
2014English

Adherence to Oral Antihyperglycemic Agents (Dipeptidyl Peptidase-4 Inhibitors and Biguanides) and Its Associated Factors in Patients With Type 2 Diabetes

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2019English

Transitions of Care for People With Type 2 Diabetes: Utilization of Antihyperglycemic Agents Pre- And Post-Hospitalization

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Causes of the Oral Therapy Secondary Failure in Patients With Diabetes Mellitus Type 2

Scripta Medica
2009English

Should Sodium Glucose Co-Transporter 2 Inhibitors Be Considered as First Line Oral Therapy for People With Type 2 Diabetes?

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Bariatric Surgery Versus Conventional Medical Therapy for Type 2 Diabetes

New England Journal of Medicine
Medicine
2012English

Targeting Β-Cell Functions in Therapy for Type 2 Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy